EN

CN

Environmental, Social, and Governance

Environmental, Social, and Governance

Patient First, Medicine for Good
Continuously enhancing the company's overall ESG performance

Health Empowerment

Innovation-Driven

Gan & Lee Pharmaceuticals complies with Chinese and international laws and regulations, including the "Drug Administration Law of the People's Republic of China" and the "Provisions for Drug Registration", and refers to international technical guidelines and industry standards such as the International Conference on Harmonization (ICH), to build a systematic, full-chain R&D project management system centered on the "Management System for Drug R&D Projects". This system covers the entire R&D process, forming an innovation management mechanism.

Our Performance
886people
R&D Personnel
45.71%
R&D personnel with master's or doctoral degrees
1.341billion CNY
Annual R&D Investment
33.08%
R&D investment as a percentage of revenue
19Studies
New drug clinical studies
Data as of December 31, 2025
Quality and Safety of Product and Service

Quality and Safety of Product and Service

To ensure the safety and quality of products throughout their lifecycle, Gan & Lee Pharmaceuticals has established a quality governance system and strict quality management standards covering the headquarters and subsidiaries and ensuring the consistent implementation of high standards across the entities.

Based on the National Medical Products Administration (NMPA) Good Manufacturing Practice (GMP) and ICH Q10, the company has formulated the guiding document "Quality Manual", which clarifies the quality policy and quality objectives, and has built a quality management system based on the entire lifecycle of the drug. Through quality management systems and standard operating procedures (SOPs) covering the entire product chain, we effectively reduce production variability, ensure stable and controllable product quality, and continuously meet the compliance requirements of global drug regulatory agencies such as the NMPA, European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA), and Medicines and Healthcare Products Regulatory Agency (MHRA).

Supply Chain Security

Supply chain risk management runs through the entire chain of suppliers, procurement, production-sales coordination, warehousing, and logistics. Gan & Lee Pharmaceuticals implements management at each stage through standardized processes, refined control, and institutional construction to identify, prevent and effectively respond to potential risks and ensure the stability, compliance, and efficiency of the supply chain.

Our Performance
Management Dimension
Key Performance
Supply Assurance
Ensure stable supply for the global market and avoid delays caused by supply chain disruptions
Warehousing and Inventory
Ensure efficient turnover of production materials, guarantee accuracy and safety of inventory and achieve inventory efficiency targets
Logistics and Transportation
Control transportation costs, ensure timely delivery and transportation quality
Quality and Compliance
Fully meet the assessment requirements under Good Manufacturing Practice (GMP)
Supply Chain Security
Related Policies
Gan & Lee Pharmaceuticals. Supply Chain Management System Gan & Lee Pharmaceuticals. Implementation Rules for Supplier Code of Conduct Management